Article
Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.
PLoS pathogens - 1 Sept 2009
Rong Rong, Li Bing, Lynch Rebecca M, Haaland Richard E, Murphy Megan K, Mulenga Joseph, Allen Susan A, Pinter Abraham, Shaw George M, Hunter Eric, Robinson James E, Gnanakaran S, Derdeyn Cynthia A
Abstract excerpt
One aim for an HIV vaccine is to elicit neutralizing antibodies (Nab) that can limit replication of genetically diverse viruses and prevent establishment of a new infection. Thus, identifying the strengths and weaknesses of Nab during the early stages of natural infection could prove useful in achieving this goal. Here we demonstrate that viral escape readily occurred despite the development of high titer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
